These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32154454)

  • 21. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience.
    Chen P; Mao M; Wang C; Zhang X; Zhao X; Gao Y; Luo Y; Zhou Y
    Front Endocrinol (Lausanne); 2023; 14():1044782. PubMed ID: 36875477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.
    Teisseyre M; Perrochia H; Reboul P; Cariou S; Renaud S; Aglae C; Moranne O
    BMC Nephrol; 2020 May; 21(1):196. PubMed ID: 32448215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience.
    Wang YW; Wang XH; Wang HX; Yu RH
    World J Clin Cases; 2023 Jan; 11(3):566-575. PubMed ID: 36793628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features and outcomes of PLA2R-related membranous nephropathy with renal glycosuria.
    Zhang P; Xu F; Liu X; Hu Z; Liang D; Liang S; Zhu X; Yang F; Zeng C
    Clin Nephrol; 2024 Nov; 102(5):273-284. PubMed ID: 39099383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience.
    Bagchi S; Subbiah AK; Bhowmik D; Mahajan S; Yadav RK; Kalaivani M; Singh G; Dinda A; Kumar Agarwal S
    Clin Kidney J; 2018 Jun; 11(3):337-341. PubMed ID: 29942496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy.
    Hu X; Zhang M; Xu J; Gao C; Yu X; Li X; Ren H; Wang W; Xie J
    Clin J Am Soc Nephrol; 2024 Dec; 19(12):1594-1602. PubMed ID: 39207845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy.
    Vink CH; Logt AV; van der Molen RG; Hofstra JM; Wetzels JFM
    Kidney Int Rep; 2023 Mar; 8(3):432-441. PubMed ID: 36938074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab.
    Alberici F; Mescia F; Scolari F
    Clin Kidney J; 2023 Sep; 16(9):1426-1431. PubMed ID: 37669306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized rituximab regimen versus recommended regimen for idiopathic membranous nephropathy: A single-center retrospective cohort study.
    Yan P; Fang X; Ke B
    Int Immunopharmacol; 2024 Mar; 130():111718. PubMed ID: 38377859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases.
    Malatesta-Muncher R; Eldin KW; Beck LH; Michael M
    Pediatr Nephrol; 2018 Jun; 33(6):1089-1092. PubMed ID: 29546599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study.
    Chen X; Jiao S; Li S; Li J; Li P; Song F; Yan Z
    Balkan Med J; 2023 Jul; 40(4):287-293. PubMed ID: 37260416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome.
    Perna A; Ruggiero B; Podestà MA; Perico L; Orisio S; Debiec H; Remuzzi G; Ruggenenti P
    Front Pharmacol; 2022; 13():958136. PubMed ID: 36120314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive and prognostic value of peripheral blood antigen-specific memory B cells in phospholipase A2 receptor-associated membranous nephropathy.
    Zhu R; Tang H; Howard L; Waldman M; Zhu Q
    medRxiv; 2023 Aug; ():. PubMed ID: 37790554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy.
    Song EJ; Jeong KH; Yang YA; Lim JH; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Kidney Res Clin Pract; 2018 Sep; 37(3):248-256. PubMed ID: 30254849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
    Dong D; Fan TT; Wang YY; Zhang L; Song L; Zhang L
    BMC Nephrol; 2019 Dec; 20(1):444. PubMed ID: 31791262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.